Svb Wealth LLC Vertex Pharmaceuticals Inc Transaction History

Svb Wealth LLC

  • $117 Million
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$392.81 - $485.53 $24,747 - $30,588
63 Added 0.37%
17,201 $8.06 Million
Q1 2024

May 15, 2024
SELL
$407.69 - $446.08 $22,830 - $24,980
-56 Reduced 0.33%
17,138 $7.16 Million
Q4 2023

Jan 30, 2024
SELL
$343.0 - $410.68 $50,764 - $60,780
-148 Reduced 0.85%
17,194 $7 Million
Q3 2023

Oct 23, 2023
SELL
$338.18 - $362.46 $71,355 - $76,479
-211 Reduced 1.2%
17,342 $6.03 Million
Q2 2023

Jul 24, 2023
SELL
$314.42 - $351.91 $149,035 - $166,805
-474 Reduced 2.63%
17,553 $6.18 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $122,638 - $139,902
-433 Reduced 2.35%
18,027 $5.68 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $75,440 - $84,870
-264 Reduced 1.41%
18,460 $5.33 Million
Q3 2022

Nov 09, 2022
BUY
$273.83 - $305.53 $426,900 - $476,321
1,559 Added 9.08%
18,724 $5.42 Million
Q2 2022

Aug 16, 2022
BUY
$234.96 - $292.55 $69,783 - $86,887
297 Added 1.76%
17,165 $4.84 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $109,824 - $129,441
496 Added 3.03%
16,868 $4.4 Million
Q4 2021

Feb 15, 2022
BUY
$177.01 - $223.45 $17,346 - $21,898
98 Added 0.6%
16,372 $3.6 Million
Q3 2021

Nov 09, 2021
SELL
$181.39 - $202.99 $147,288 - $164,827
-812 Reduced 4.75%
16,274 $2.95 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $60,184 - $70,973
321 Added 1.91%
17,086 $3.45 Million
Q1 2021

May 11, 2021
SELL
$207.02 - $241.31 $3.19 Million - $3.72 Million
-15,420 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$207.01 - $276.09 $71,004 - $94,698
343 Added 2.27%
15,420 $3.64 Million
Q3 2020

Nov 10, 2020
BUY
$255.65 - $303.1 $248,747 - $294,916
973 Added 6.9%
15,077 $4.1 Million
Q2 2020

Aug 05, 2020
BUY
$225.48 - $295.8 $107,103 - $140,505
475 Added 3.49%
14,104 $4.1 Million
Q1 2020

May 11, 2020
SELL
$199.77 - $247.81 $88,498 - $109,779
-443 Reduced 3.15%
13,629 $3.24 Million
Q4 2019

Feb 13, 2020
BUY
$166.71 - $223.91 $34,508 - $46,349
207 Added 1.49%
14,072 $3.08 Million
Q3 2019

Nov 01, 2019
BUY
$166.23 - $187.09 $89,764 - $101,028
540 Added 4.05%
13,865 $2.35 Million
Q1 2019

May 14, 2019
SELL
$163.73 - $194.7 $7,204 - $8,566
-44 Reduced 0.33%
13,325 $2.45 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $21,875 - $27,678
-144 Reduced 1.07%
13,369 $2.22 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $34,887 - $40,089
-208 Reduced 1.52%
13,513 $2.6 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $18,215 - $21,245
-125 Reduced 0.9%
13,721 $2.33 Million
Q1 2018

May 11, 2018
SELL
$151.6 - $177.13 $37,142 - $43,396
-245 Reduced 1.74%
13,846 $2.26 Million
Q4 2017

Feb 13, 2018
SELL
$137.28 - $155.55 $107,352 - $121,640
-782 Reduced 5.26%
14,091 $2.11 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $2.2 Million - $2.41 Million
14,873
14,873 $2.26 Million

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email